PeptidePedia The community reference

Revision history of Survodutide

Page history·28 revisions·page 1 of 1

Revision history for Survodutide. The list runs newest first. Byte counts are the size of the page source at that revision; the figure beside each is the change from the previous one. cur compares a revision with the current version, prev with the one before it.

28Revisions
26Distinct editors
5,445Current size (bytes)
6 Nov 2024Created

Most active on this page: IcodecIndra (3), IncretinIvo (1), NauseaNoor (1), MolarMassMaeve (1), NeutralNikolai (1), Chromatokid (1).

  1. cur | prev 19:28, 17 Jul 2026 CustomsClarke (talk | contribs) 5,445 bytes ±0 m the lead claimed weekly dosing for a compound dosed daily; corrected
  2. cur | prev 07:32, 13 Jun 2026 ArchiveAudit (talk | contribs) 5,445 bytes ±0 state which salt form the mass in the infobox refers to [rollback]
  3. cur | prev 21:34, 13 May 2026 StubSorterBot (talk | contribs) 5,445 bytes ±0 m b bot: sort category members [rollback]
  4. cur | prev 16:20, 9 Apr 2026 LiraLotte (talk | contribs) 5,445 bytes ±0 expand §Status and material sold under the name [rollback]
  5. cur | prev 02:01, 13 Mar 2026 CiteBot (talk | contribs) 5,445 bytes ±0 m b bot: expand DOI to full citation [rollback]
  6. cur | prev 08:48, 9 Feb 2026 CuriousCallum (talk | contribs) 5,445 bytes ±0 give the isoelectric point with the method it was determined by [rollback]
  7. cur | prev 02:13, 12 Jan 2026 SPPS_Sorrel (talk | contribs) 5,445 bytes ±0 m add the peptide length to the infobox [rollback]
  8. cur | prev 20:07, 12 Dec 2025 ShortageShona (talk | contribs) 5,445 bytes ±0 state plainly that the research-use-only form is not approved for human use [rollback]
  9. cur | prev 21:09, 12 Nov 2025 EndpointEnid (talk | contribs) 5,445 bytes ±0 expand §Status and material sold under the name [rollback]
  10. cur | prev 12:31, 23 Oct 2025 Peptide_Pete (talk | contribs) 5,445 bytes ±0 m add the molecular formula to the infobox [rollback]
  11. cur | prev 04:09, 23 Sep 2025 ExenatideEzra (talk | contribs) 5,445 bytes +143 attribute the potency comparison to the head-to-head trial rather than to two separate ones [rollback]
  12. cur | prev 17:15, 26 Aug 2025 OralSemaOswin (talk | contribs) 5,302 bytes ±0 expand §Design and rationale [rollback]
  13. cur | prev 09:57, 2 Aug 2025 IcodecIndra (talk | contribs) 5,302 bytes +774 add the receptor targets to the lead sentence [rollback]
  14. cur | prev 12:55, 7 Jul 2025 INN_Ingrid (talk | contribs) 4,528 bytes +18 m give the INN alongside the trade name at first mention [rollback]
  15. cur | prev 09:05, 11 Jun 2025 NotabilityNoa (talk | contribs) 4,510 bytes ±0 add CAS number, sourced [rollback]
  16. cur | prev 00:40, 24 May 2025 TirzTaxonomist (talk | contribs) 4,510 bytes ±0 rm the equipotency claim — the cited paper does not make it [rollback]
  17. cur | prev 23:26, 25 Apr 2025 TSH_Tallulah (talk | contribs) 4,510 bytes +40 m convert the substitution list to a table so the analogues line up [rollback]
  18. cur | prev 21:20, 8 Apr 2025 SemaglutideSasha (talk | contribs) 4,470 bytes ±0 m add the year of first marketing authorisation, with the regulator named [rollback]
  19. cur | prev 02:07, 12 Mar 2025 AmylinAmos (talk | contribs) 4,470 bytes +465 expand §Design and rationale [rollback]
  20. cur | prev 17:46, 25 Feb 2025 ArchiveBot (talk | contribs) 4,005 bytes +32 m b bot: add drug-class category [rollback]
  21. cur | prev 15:54, 4 Feb 2025 FmocFrancis (talk | contribs) 3,973 bytes ±0 give the strength per pen as well as per millilitre [rollback]
  22. cur | prev 22:05, 18 Jan 2025 Chromatokid (talk | contribs) 3,973 bytes +648 the half-life in the lead was the terminal figure; label it as such [rollback]
  23. cur | prev 12:31, 29 Dec 2024 NeutralNikolai (talk | contribs) 3,325 bytes ±0 move the trade-name history out of the lead and into §Regulatory history [rollback]
  24. cur | prev 16:01, 18 Dec 2024 MolarMassMaeve (talk | contribs) 3,325 bytes +811 add the structural figure and caption it properly [rollback]
  25. cur | prev 19:47, 1 Dec 2024 IcodecIndra (talk | contribs) 2,514 bytes ±0 attribute the mechanism claim to the review rather than stating it flatly [rollback]
  26. cur | prev 11:56, 20 Nov 2024 IcodecIndra (talk | contribs) 2,514 bytes +1,058 state the substitution in one-letter code as well, per PP:MOS [rollback]
  27. cur | prev 09:58, 10 Nov 2024 NauseaNoor (talk | contribs) 1,456 bytes ±0 ce per PP:MOS [rollback]
  28. cur | prev 09:00, 6 Nov 2024 IncretinIvo (talk | contribs) 1,456 bytes +1,456 N create article — compound stub [rollback]